undamentalytics Newsletter
Sign in

BIO KEY International Inc income statement

In fiscal 2025, BIO KEY International Inc reported revenue of $5.9m, down 14.3% on the year before, operating income of −$6.8m (a -115.0% margin) and net income of −$7.2m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue44424536423578767
Cost of revenue11101113421226111
Gross profit33323423−0−02351655
Research and development11112222111232333
Selling, general and administrative33234446556698766
Operating income−1−10−3−2−2−4−40−1−5−5−10−9−4−7−6
Interest expense1000—0———14000000
Net interest income————00000————————
Income before tax———————————0−12−9−4−7−6
Income tax—0—000−000000−0−0−000
Net income−0−20−3−2−2−4−4−7−15−10−5−12−9−4−7−6
Diluted EPS−$0.01−$4.32$0.00−$103.68−$6.48−$51.84−$16.02−$13.68−$13.14−$147.78−$37.44−$11.70—————
Diluted shares (average)—————————————————
EBITDA−1−10−2−2−2−4−40−1−5−5−10−9−4−7−6

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AUR vs BKYIBKYI vs RYETAZ vs BKYI

More: Application Software stocks compared, Technology sector, rankings of US companies

Figures from BIO KEY International Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to BIO KEY International Inc.